Page last updated: 2024-09-05

anacardic acid and nsc 663284

anacardic acid has been researched along with nsc 663284 in 1 studies

Compound Research Comparison

Studies
(anacardic acid)
Trials
(anacardic acid)
Recent Studies (post-2010)
(anacardic acid)
Studies
(nsc 663284)
Trials
(nsc 663284)
Recent Studies (post-2010) (nsc 663284)
177112028020

Protein Interaction Comparison

ProteinTaxonomyanacardic acid (IC50)nsc 663284 (IC50)
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus2.63
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 22.63
M-phase inducer phosphatase 1Homo sapiens (human)1.015
M-phase inducer phosphatase 2Homo sapiens (human)0.77
M-phase inducer phosphatase 3Homo sapiens (human)0.505
Dual specificity protein phosphatase 3Homo sapiens (human)4
N-lysine methyltransferase KMT5AHomo sapiens (human)0.21

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, CZ; Guo, H; Hu, X; Klumpp-Thomas, C; Michael, SG; Shen, M; Shinn, P; Xu, M; Zheng, W; Zhu, W1

Other Studies

1 other study(ies) available for anacardic acid and nsc 663284

ArticleYear
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-throughput Screening.
    bioRxiv : the preprint server for biology, 2020, Aug-11

    Topics:

2020